发明名称 |
NKG2D-FC FOR IMMUNOTHERAPY |
摘要 |
<p>Methods for cancer immunotherapy are provided. The methods involve the use of a chimeric molecule (e.g., fusion protein) comprising an NKG2D portion and an Fc portion, which binds one or more NKG2D ligands. The methods disclosed herein are useful for the treatment of cancer that is associated with abnormal expression of one or more NKG2D ligands.</p> |
申请公布号 |
CA2747011(A1) |
申请公布日期 |
2010.07.15 |
申请号 |
CA20092747011 |
申请日期 |
2009.12.18 |
申请人 |
DANA-FARBER CANCER INSTITUTE, INC. |
发明人 |
DRANOFF, GLENN;VANNEMAN, MATTHEW;FREEMAN, GORDON |
分类号 |
A61K38/16;A61P35/00 |
主分类号 |
A61K38/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|